Abivax S.A. ABVX
$73.20 −$7.45 (-9.24%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $74.95 +2.39%
Open$79.01
Prev close$80.65
Day range$62.70 – $79.74
Volume14.85M
Market cap$6.41B
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±4.7%last 10 reports
Closed higher4 of 1040% of the time
Best reaction+21.9%
Worst reaction-5.9%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q2 | 21 Sep 2026 | None | ±8.1% | -4.99% | Within range |
| 2026/Q1 | 22 May 2026 | None | ±15.4% | +3.62% | Within range |
| 2025/Q4 | 23 Mar 2026 | None | ±9.6% | -4.55% | Within range |
| 2025/Q3 | 15 Dec 2025 | After Market | ±12.4% | -5.88% | Within range |
| 2025/Q2 | 8 Sep 2025 | None | – | -0.83% | – |
| 2025/Q1 | 2 Jun 2025 | After Market | – | +21.89% | – |
| 2024/Q4 | 24 Mar 2025 | After Market | – | -0.41% | – |
| 2024/Q3 | 7 Nov 2024 | Pre Market | – | +1.35% | – |
| 2024/Q2 | 9 Sep 2024 | Pre Market | – | -2.83% | – |
| 2023/Q4 | 2 Apr 2024 | None | – | +0.50% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q2, ended Jun 2026 · reported in EUR
Revenue€0.00
Operating profit-€84.11M-80.9% YoY
Net profit-€117.43M-142.6% YoY
Diluted EPS-€1.47-93.4% YoY
Free cash flow-€52.10M-56.2% YoY
Operating cash flow-€51.99M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Return on equity-252.3%
Return on assets-137.9%
Return on invested capital-190.2%
Current ratio5.97
Liabilities / assets20.8%
Cash & investments€410.68M
Total debt€137,000.00
Net cash (debt)€410.55M
No comments yet — be the first to weigh in on ABVX.
Sign in to join the discussion.